These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study. Xu X; Liang MY; Zhao LR; Wang JL; Zhang XH Platelets; 2024 Dec; 35(1):2380366. PubMed ID: 39087677 [TBL] [Abstract][Full Text] [Related]
5. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. Psaila B; Bussel JB; Frelinger AL; Babula B; Linden MD; Li Y; Barnard MR; Tate C; Feldman EJ; Michelson AD J Thromb Haemost; 2011 Nov; 9(11):2302-10. PubMed ID: 21920014 [TBL] [Abstract][Full Text] [Related]
6. Biological stratification of clinical disease courses in childhood immune thrombocytopenia. Schmidt DE; Heitink-Pollé KMJ; Mertens B; Porcelijn L; Kapur R; van der Schoot CE; Vidarsson G; van der Bom JG; Bruin MCA; de Haas M J Thromb Haemost; 2021 Apr; 19(4):1071-1081. PubMed ID: 33386662 [TBL] [Abstract][Full Text] [Related]
7. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia. Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984 [TBL] [Abstract][Full Text] [Related]
8. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group. Neunert C; Heitink-Polle KMJ; Lambert MP Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D; J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158 [TBL] [Abstract][Full Text] [Related]
10. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases. Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513 [TBL] [Abstract][Full Text] [Related]
11. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
13. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Barsam SJ; Psaila B; Forestier M; Page LK; Sloane PA; Geyer JT; Villarica GO; Ruisi MM; Gernsheimer TB; Beer JH; Bussel JB Blood; 2011 May; 117(21):5723-32. PubMed ID: 21389318 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial. Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA; Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954 [TBL] [Abstract][Full Text] [Related]
16. [Idiopathic thrombocytopenic purpura in children]. Gebauer E; Vijatov G Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia. Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309 [TBL] [Abstract][Full Text] [Related]
20. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT; Gonzalez CE; Sandler SG Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]